News Release January 29, 2004 ConsumerLab.com finds lutein supplements vary widely in strength but most meet ingredient claims Right amount of antioxidant compound may reduce risk of blindness WHITE PLAINS, NY January 29, 2004 ConsumerLab.com announced today that only one of the 19 lutein/zeaxanthin supplements it recently tested failed to contain the claimed ingredients
Berb Evail Designs for Health supplement available through Dr
Development is being led by Novo Nordisk, the same company behind semaglutide (Ozempic, Wegovy)
Friedman has negotiated a clinic price at several compounding pharmacies that is substantially lower cost than pharmacy prices
Other supplements sometimes used include alpha-lipoic acid and milk thistle (silymarin), which support liver function and glutathione recycling
Scott Brunner of the Alliance for Pharmacy Compounding has described this as the start of a "protracted process." Even under the most optimistic scenario, broad clinical availability of legally compounded versions of these peptides is likely a mid-to-late 2026 proposition at the earliest and possibly longer if the political or regulatory environment shifts